Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
838.1 INR | +4.45% | +10.48% | +21.89% |
04-23 | Max Healthcare Institute Acquires Additional 3% Stake in Sandhya Hydro Power | MT |
04-23 | AppLovin Corporation : The future of app marketplace? |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 59.46 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+21.89% | 9.35B | B- | ||
-14.92% | 84.68B | B- | ||
+13.30% | 81.12B | C+ | ||
+11.62% | 29.59B | C+ | ||
-12.71% | 16.73B | B | ||
-1.96% | 16.36B | A- | ||
-2.63% | 14.92B | A- | ||
-31.58% | 11.77B | - | - | |
+0.66% | 11.72B | A- | ||
+27.44% | 11.71B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MAXHEALTH Stock
- Ratings Max Healthcare Institute Limited